nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—CYP3A4—type 2 diabetes mellitus	0.165	1	CbGaD
Hydromorphone—UGT1A9—Nateglinide—type 2 diabetes mellitus	0.0724	0.128	CbGbCtD
Hydromorphone—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0396	0.0701	CbGbCtD
Hydromorphone—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0396	0.0701	CbGbCtD
Hydromorphone—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0366	0.0647	CbGbCtD
Hydromorphone—PTGS1—Nateglinide—type 2 diabetes mellitus	0.03	0.0531	CbGbCtD
Hydromorphone—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0288	0.0509	CbGbCtD
Hydromorphone—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0221	0.039	CbGbCtD
Hydromorphone—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0202	0.0357	CbGbCtD
Hydromorphone—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0188	0.0332	CbGbCtD
Hydromorphone—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.016	0.0282	CbGbCtD
Hydromorphone—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.016	0.0282	CbGbCtD
Hydromorphone—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0147	0.026	CbGbCtD
Hydromorphone—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0146	0.0258	CbGbCtD
Hydromorphone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0144	0.0255	CbGbCtD
Hydromorphone—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0142	0.0252	CbGbCtD
Hydromorphone—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0135	0.0238	CbGbCtD
Hydromorphone—CYP2C9—Valsartan—type 2 diabetes mellitus	0.013	0.023	CbGbCtD
Hydromorphone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0128	0.0227	CbGbCtD
Hydromorphone—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0121	0.0214	CbGbCtD
Hydromorphone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0117	0.0208	CbGbCtD
Hydromorphone—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0116	0.0205	CbGbCtD
Hydromorphone—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0111	0.0196	CbGbCtD
Hydromorphone—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0106	0.0188	CbGbCtD
Hydromorphone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0103	0.0181	CbGbCtD
Hydromorphone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00928	0.0164	CbGbCtD
Hydromorphone—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00817	0.0144	CbGbCtD
Hydromorphone—CYP2C9—Losartan—type 2 diabetes mellitus	0.00747	0.0132	CbGbCtD
Hydromorphone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00703	0.0124	CbGbCtD
Hydromorphone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00674	0.0119	CbGbCtD
Hydromorphone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00674	0.0119	CbGbCtD
Hydromorphone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00638	0.0113	CbGbCtD
Hydromorphone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00475	0.0084	CbGbCtD
Hydromorphone—CYP3A4—Losartan—type 2 diabetes mellitus	0.00434	0.00768	CbGbCtD
Hydromorphone—Dihydrocodeine—CYP3A4—type 2 diabetes mellitus	0.000234	0.129	CrCbGaD
Hydromorphone—Oxymorphone—CYP3A4—type 2 diabetes mellitus	0.000205	0.113	CrCbGaD
Hydromorphone—Ethylmorphine—CYP3A4—type 2 diabetes mellitus	0.000196	0.108	CrCbGaD
Hydromorphone—Hydrocodone—CYP3A4—type 2 diabetes mellitus	0.000179	0.0988	CrCbGaD
Hydromorphone—Dextromethorphan—CYP2E1—type 2 diabetes mellitus	0.000168	0.0928	CrCbGaD
Hydromorphone—Oxycodone—CYP3A4—type 2 diabetes mellitus	0.000164	0.0901	CrCbGaD
Hydromorphone—Codeine—CYP3A4—type 2 diabetes mellitus	0.000156	0.086	CrCbGaD
Hydromorphone—Naloxone—CYP3A4—type 2 diabetes mellitus	0.00015	0.0824	CrCbGaD
Hydromorphone—Naloxone—ALB—type 2 diabetes mellitus	0.000131	0.0719	CrCbGaD
Hydromorphone—Morphine—CYP3A4—type 2 diabetes mellitus	0.000126	0.0696	CrCbGaD
Hydromorphone—Dextromethorphan—CYP3A4—type 2 diabetes mellitus	0.000106	0.0584	CrCbGaD
Hydromorphone—Myalgia—Irbesartan—type 2 diabetes mellitus	7.37e-05	0.000385	CcSEcCtD
Hydromorphone—Shock—Metformin—type 2 diabetes mellitus	7.37e-05	0.000385	CcSEcCtD
Hydromorphone—Insomnia—Orlistat—type 2 diabetes mellitus	7.35e-05	0.000384	CcSEcCtD
Hydromorphone—Malaise—Losartan—type 2 diabetes mellitus	7.35e-05	0.000384	CcSEcCtD
Hydromorphone—Anxiety—Irbesartan—type 2 diabetes mellitus	7.35e-05	0.000384	CcSEcCtD
Hydromorphone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	7.35e-05	0.000384	CcSEcCtD
Hydromorphone—Nervous system disorder—Metformin—type 2 diabetes mellitus	7.35e-05	0.000384	CcSEcCtD
Hydromorphone—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.33e-05	0.000383	CcSEcCtD
Hydromorphone—Vertigo—Losartan—type 2 diabetes mellitus	7.32e-05	0.000382	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	7.32e-05	0.000382	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.32e-05	0.000382	CcSEcCtD
Hydromorphone—Somnolence—Valsartan—type 2 diabetes mellitus	7.31e-05	0.000382	CcSEcCtD
Hydromorphone—Syncope—Losartan—type 2 diabetes mellitus	7.31e-05	0.000382	CcSEcCtD
Hydromorphone—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.3e-05	0.000381	CcSEcCtD
Hydromorphone—Leukopenia—Losartan—type 2 diabetes mellitus	7.3e-05	0.000381	CcSEcCtD
Hydromorphone—Discomfort—Irbesartan—type 2 diabetes mellitus	7.29e-05	0.00038	CcSEcCtD
Hydromorphone—Skin disorder—Metformin—type 2 diabetes mellitus	7.28e-05	0.00038	CcSEcCtD
Hydromorphone—Immune system disorder—Ramipril—type 2 diabetes mellitus	7.25e-05	0.000379	CcSEcCtD
Hydromorphone—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.24e-05	0.000378	CcSEcCtD
Hydromorphone—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.24e-05	0.000378	CcSEcCtD
Hydromorphone—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	7.24e-05	0.000378	CcSEcCtD
Hydromorphone—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.21e-05	0.000377	CcSEcCtD
Hydromorphone—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.21e-05	0.000377	CcSEcCtD
Hydromorphone—Palpitations—Losartan—type 2 diabetes mellitus	7.2e-05	0.000376	CcSEcCtD
Hydromorphone—Nausea—Glimepiride—type 2 diabetes mellitus	7.18e-05	0.000375	CcSEcCtD
Hydromorphone—Arrhythmia—Ramipril—type 2 diabetes mellitus	7.17e-05	0.000375	CcSEcCtD
Hydromorphone—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.17e-05	0.000374	CcSEcCtD
Hydromorphone—Nausea—Sitagliptin—type 2 diabetes mellitus	7.16e-05	0.000374	CcSEcCtD
Hydromorphone—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.16e-05	0.000374	CcSEcCtD
Hydromorphone—Asthenia—Glyburide—type 2 diabetes mellitus	7.15e-05	0.000374	CcSEcCtD
Hydromorphone—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.15e-05	0.000373	CcSEcCtD
Hydromorphone—Anorexia—Metformin—type 2 diabetes mellitus	7.14e-05	0.000373	CcSEcCtD
Hydromorphone—Cough—Losartan—type 2 diabetes mellitus	7.11e-05	0.000371	CcSEcCtD
Hydromorphone—Urticaria—Gliclazide—type 2 diabetes mellitus	7.11e-05	0.000371	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	7.1e-05	0.000371	CcSEcCtD
Hydromorphone—Fatigue—Valsartan—type 2 diabetes mellitus	7.09e-05	0.00037	CcSEcCtD
Hydromorphone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.08e-05	0.00037	CcSEcCtD
Hydromorphone—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.08e-05	0.00037	CcSEcCtD
Hydromorphone—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	7.07e-05	0.000369	CcSEcCtD
Hydromorphone—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.07e-05	0.000369	CcSEcCtD
Hydromorphone—Pruritus—Glyburide—type 2 diabetes mellitus	7.05e-05	0.000368	CcSEcCtD
Hydromorphone—Mental disorder—Ramipril—type 2 diabetes mellitus	7.03e-05	0.000367	CcSEcCtD
Hydromorphone—Constipation—Valsartan—type 2 diabetes mellitus	7.03e-05	0.000367	CcSEcCtD
Hydromorphone—Infection—Irbesartan—type 2 diabetes mellitus	7.02e-05	0.000367	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	7.02e-05	0.000366	CcSEcCtD
Hydromorphone—Fatigue—Orlistat—type 2 diabetes mellitus	7.01e-05	0.000366	CcSEcCtD
Hydromorphone—Hypotension—Metformin—type 2 diabetes mellitus	7e-05	0.000365	CcSEcCtD
Hydromorphone—Malnutrition—Ramipril—type 2 diabetes mellitus	6.99e-05	0.000365	CcSEcCtD
Hydromorphone—Erythema—Ramipril—type 2 diabetes mellitus	6.99e-05	0.000365	CcSEcCtD
Hydromorphone—Shock—Irbesartan—type 2 diabetes mellitus	6.96e-05	0.000363	CcSEcCtD
Hydromorphone—Pain—Orlistat—type 2 diabetes mellitus	6.95e-05	0.000363	CcSEcCtD
Hydromorphone—Chest pain—Losartan—type 2 diabetes mellitus	6.94e-05	0.000362	CcSEcCtD
Hydromorphone—Arthralgia—Losartan—type 2 diabetes mellitus	6.94e-05	0.000362	CcSEcCtD
Hydromorphone—Myalgia—Losartan—type 2 diabetes mellitus	6.94e-05	0.000362	CcSEcCtD
Hydromorphone—Vomiting—Bromocriptine—type 2 diabetes mellitus	6.94e-05	0.000362	CcSEcCtD
Hydromorphone—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	6.93e-05	0.000362	CcSEcCtD
Hydromorphone—Anxiety—Losartan—type 2 diabetes mellitus	6.92e-05	0.000361	CcSEcCtD
Hydromorphone—Tachycardia—Irbesartan—type 2 diabetes mellitus	6.9e-05	0.00036	CcSEcCtD
Hydromorphone—Rash—Bromocriptine—type 2 diabetes mellitus	6.88e-05	0.000359	CcSEcCtD
Hydromorphone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	6.87e-05	0.000359	CcSEcCtD
Hydromorphone—Skin disorder—Irbesartan—type 2 diabetes mellitus	6.87e-05	0.000359	CcSEcCtD
Hydromorphone—Tension—Ramipril—type 2 diabetes mellitus	6.86e-05	0.000358	CcSEcCtD
Hydromorphone—Discomfort—Losartan—type 2 diabetes mellitus	6.86e-05	0.000358	CcSEcCtD
Hydromorphone—Dysgeusia—Ramipril—type 2 diabetes mellitus	6.85e-05	0.000357	CcSEcCtD
Hydromorphone—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	6.83e-05	0.000357	CcSEcCtD
Hydromorphone—Headache—Bromocriptine—type 2 diabetes mellitus	6.83e-05	0.000357	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	6.83e-05	0.000356	CcSEcCtD
Hydromorphone—Diarrhoea—Glyburide—type 2 diabetes mellitus	6.82e-05	0.000356	CcSEcCtD
Hydromorphone—Nervousness—Ramipril—type 2 diabetes mellitus	6.79e-05	0.000354	CcSEcCtD
Hydromorphone—Dry mouth—Losartan—type 2 diabetes mellitus	6.79e-05	0.000354	CcSEcCtD
Hydromorphone—Anorexia—Irbesartan—type 2 diabetes mellitus	6.74e-05	0.000352	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	6.73e-05	0.000351	CcSEcCtD
Hydromorphone—Paraesthesia—Metformin—type 2 diabetes mellitus	6.73e-05	0.000351	CcSEcCtD
Hydromorphone—Muscle spasms—Ramipril—type 2 diabetes mellitus	6.72e-05	0.000351	CcSEcCtD
Hydromorphone—Confusional state—Losartan—type 2 diabetes mellitus	6.71e-05	0.00035	CcSEcCtD
Hydromorphone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	6.7e-05	0.00035	CcSEcCtD
Hydromorphone—Dyspnoea—Metformin—type 2 diabetes mellitus	6.68e-05	0.000349	CcSEcCtD
Hydromorphone—Somnolence—Metformin—type 2 diabetes mellitus	6.66e-05	0.000348	CcSEcCtD
Hydromorphone—Anaphylactic shock—Losartan—type 2 diabetes mellitus	6.65e-05	0.000347	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	6.65e-05	0.000347	CcSEcCtD
Hydromorphone—Infection—Losartan—type 2 diabetes mellitus	6.61e-05	0.000345	CcSEcCtD
Hydromorphone—Hypotension—Irbesartan—type 2 diabetes mellitus	6.61e-05	0.000345	CcSEcCtD
Hydromorphone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	6.6e-05	0.000344	CcSEcCtD
Hydromorphone—Dyspepsia—Metformin—type 2 diabetes mellitus	6.59e-05	0.000344	CcSEcCtD
Hydromorphone—Tremor—Ramipril—type 2 diabetes mellitus	6.55e-05	0.000342	CcSEcCtD
Hydromorphone—Shock—Losartan—type 2 diabetes mellitus	6.55e-05	0.000342	CcSEcCtD
Hydromorphone—Urticaria—Valsartan—type 2 diabetes mellitus	6.54e-05	0.000341	CcSEcCtD
Hydromorphone—Nervous system disorder—Losartan—type 2 diabetes mellitus	6.52e-05	0.000341	CcSEcCtD
Hydromorphone—Decreased appetite—Metformin—type 2 diabetes mellitus	6.51e-05	0.00034	CcSEcCtD
Hydromorphone—Abdominal pain—Valsartan—type 2 diabetes mellitus	6.5e-05	0.00034	CcSEcCtD
Hydromorphone—Tachycardia—Losartan—type 2 diabetes mellitus	6.49e-05	0.000339	CcSEcCtD
Hydromorphone—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	6.49e-05	0.000339	CcSEcCtD
Hydromorphone—Nausea—Bromocriptine—type 2 diabetes mellitus	6.48e-05	0.000338	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	6.47e-05	0.000338	CcSEcCtD
Hydromorphone—Fatigue—Metformin—type 2 diabetes mellitus	6.46e-05	0.000337	CcSEcCtD
Hydromorphone—Urticaria—Orlistat—type 2 diabetes mellitus	6.46e-05	0.000337	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6.44e-05	0.000336	CcSEcCtD
Hydromorphone—Hyperhidrosis—Losartan—type 2 diabetes mellitus	6.43e-05	0.000336	CcSEcCtD
Hydromorphone—Abdominal pain—Orlistat—type 2 diabetes mellitus	6.43e-05	0.000336	CcSEcCtD
Hydromorphone—Body temperature increased—Orlistat—type 2 diabetes mellitus	6.43e-05	0.000336	CcSEcCtD
Hydromorphone—Asthenia—Gliclazide—type 2 diabetes mellitus	6.42e-05	0.000335	CcSEcCtD
Hydromorphone—Agitation—Ramipril—type 2 diabetes mellitus	6.42e-05	0.000335	CcSEcCtD
Hydromorphone—Constipation—Metformin—type 2 diabetes mellitus	6.41e-05	0.000334	CcSEcCtD
Hydromorphone—Angioedema—Ramipril—type 2 diabetes mellitus	6.39e-05	0.000333	CcSEcCtD
Hydromorphone—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.35e-05	0.000331	CcSEcCtD
Hydromorphone—Anorexia—Losartan—type 2 diabetes mellitus	6.34e-05	0.000331	CcSEcCtD
Hydromorphone—Vomiting—Glyburide—type 2 diabetes mellitus	6.34e-05	0.000331	CcSEcCtD
Hydromorphone—Pruritus—Gliclazide—type 2 diabetes mellitus	6.33e-05	0.000331	CcSEcCtD
Hydromorphone—Malaise—Ramipril—type 2 diabetes mellitus	6.3e-05	0.000329	CcSEcCtD
Hydromorphone—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.3e-05	0.000329	CcSEcCtD
Hydromorphone—Rash—Glyburide—type 2 diabetes mellitus	6.29e-05	0.000328	CcSEcCtD
Hydromorphone—Somnolence—Irbesartan—type 2 diabetes mellitus	6.28e-05	0.000328	CcSEcCtD
Hydromorphone—Dermatitis—Glyburide—type 2 diabetes mellitus	6.28e-05	0.000328	CcSEcCtD
Hydromorphone—Vertigo—Ramipril—type 2 diabetes mellitus	6.28e-05	0.000328	CcSEcCtD
Hydromorphone—Syncope—Ramipril—type 2 diabetes mellitus	6.27e-05	0.000327	CcSEcCtD
Hydromorphone—Leukopenia—Ramipril—type 2 diabetes mellitus	6.26e-05	0.000327	CcSEcCtD
Hydromorphone—Headache—Glyburide—type 2 diabetes mellitus	6.25e-05	0.000326	CcSEcCtD
Hydromorphone—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.22e-05	0.000325	CcSEcCtD
Hydromorphone—Hypotension—Losartan—type 2 diabetes mellitus	6.22e-05	0.000325	CcSEcCtD
Hydromorphone—Palpitations—Ramipril—type 2 diabetes mellitus	6.18e-05	0.000323	CcSEcCtD
Hydromorphone—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.17e-05	0.000322	CcSEcCtD
Hydromorphone—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.15e-05	0.000321	CcSEcCtD
Hydromorphone—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.14e-05	0.000321	CcSEcCtD
Hydromorphone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.13e-05	0.00032	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.13e-05	0.00032	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	6.1e-05	0.000319	CcSEcCtD
Hydromorphone—Cough—Ramipril—type 2 diabetes mellitus	6.1e-05	0.000318	CcSEcCtD
Hydromorphone—Fatigue—Irbesartan—type 2 diabetes mellitus	6.1e-05	0.000318	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.06e-05	0.000316	CcSEcCtD
Hydromorphone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.06e-05	0.000316	CcSEcCtD
Hydromorphone—Convulsion—Ramipril—type 2 diabetes mellitus	6.06e-05	0.000316	CcSEcCtD
Hydromorphone—Pain—Irbesartan—type 2 diabetes mellitus	6.05e-05	0.000316	CcSEcCtD
Hydromorphone—Constipation—Irbesartan—type 2 diabetes mellitus	6.05e-05	0.000316	CcSEcCtD
Hydromorphone—Insomnia—Losartan—type 2 diabetes mellitus	6.02e-05	0.000314	CcSEcCtD
Hydromorphone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	5.99e-05	0.000313	CcSEcCtD
Hydromorphone—Paraesthesia—Losartan—type 2 diabetes mellitus	5.97e-05	0.000312	CcSEcCtD
Hydromorphone—Urticaria—Metformin—type 2 diabetes mellitus	5.95e-05	0.000311	CcSEcCtD
Hydromorphone—Chest pain—Ramipril—type 2 diabetes mellitus	5.95e-05	0.000311	CcSEcCtD
Hydromorphone—Arthralgia—Ramipril—type 2 diabetes mellitus	5.95e-05	0.000311	CcSEcCtD
Hydromorphone—Myalgia—Ramipril—type 2 diabetes mellitus	5.95e-05	0.000311	CcSEcCtD
Hydromorphone—Dyspnoea—Losartan—type 2 diabetes mellitus	5.93e-05	0.00031	CcSEcCtD
Hydromorphone—Anxiety—Ramipril—type 2 diabetes mellitus	5.93e-05	0.00031	CcSEcCtD
Hydromorphone—Nausea—Glyburide—type 2 diabetes mellitus	5.92e-05	0.000309	CcSEcCtD
Hydromorphone—Abdominal pain—Metformin—type 2 diabetes mellitus	5.92e-05	0.000309	CcSEcCtD
Hydromorphone—Dizziness—Gliclazide—type 2 diabetes mellitus	5.92e-05	0.000309	CcSEcCtD
Hydromorphone—Somnolence—Losartan—type 2 diabetes mellitus	5.91e-05	0.000309	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	5.91e-05	0.000309	CcSEcCtD
Hydromorphone—Asthenia—Valsartan—type 2 diabetes mellitus	5.9e-05	0.000308	CcSEcCtD
Hydromorphone—Discomfort—Ramipril—type 2 diabetes mellitus	5.88e-05	0.000307	CcSEcCtD
Hydromorphone—Dyspepsia—Losartan—type 2 diabetes mellitus	5.86e-05	0.000306	CcSEcCtD
Hydromorphone—Asthenia—Orlistat—type 2 diabetes mellitus	5.83e-05	0.000305	CcSEcCtD
Hydromorphone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	5.83e-05	0.000304	CcSEcCtD
Hydromorphone—Pruritus—Valsartan—type 2 diabetes mellitus	5.82e-05	0.000304	CcSEcCtD
Hydromorphone—Dry mouth—Ramipril—type 2 diabetes mellitus	5.82e-05	0.000304	CcSEcCtD
Hydromorphone—Decreased appetite—Losartan—type 2 diabetes mellitus	5.78e-05	0.000302	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	5.78e-05	0.000302	CcSEcCtD
Hydromorphone—Confusional state—Ramipril—type 2 diabetes mellitus	5.75e-05	0.0003	CcSEcCtD
Hydromorphone—Pruritus—Orlistat—type 2 diabetes mellitus	5.75e-05	0.0003	CcSEcCtD
Hydromorphone—Fatigue—Losartan—type 2 diabetes mellitus	5.74e-05	0.000299	CcSEcCtD
Hydromorphone—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	5.7e-05	0.000298	CcSEcCtD
Hydromorphone—Vomiting—Gliclazide—type 2 diabetes mellitus	5.69e-05	0.000297	CcSEcCtD
Hydromorphone—Pain—Losartan—type 2 diabetes mellitus	5.69e-05	0.000297	CcSEcCtD
Hydromorphone—Constipation—Losartan—type 2 diabetes mellitus	5.69e-05	0.000297	CcSEcCtD
Hydromorphone—Rash—Gliclazide—type 2 diabetes mellitus	5.65e-05	0.000295	CcSEcCtD
Hydromorphone—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.64e-05	0.000294	CcSEcCtD
Hydromorphone—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.63e-05	0.000294	CcSEcCtD
Hydromorphone—Urticaria—Irbesartan—type 2 diabetes mellitus	5.62e-05	0.000293	CcSEcCtD
Hydromorphone—Shock—Ramipril—type 2 diabetes mellitus	5.61e-05	0.000293	CcSEcCtD
Hydromorphone—Headache—Gliclazide—type 2 diabetes mellitus	5.61e-05	0.000293	CcSEcCtD
Hydromorphone—Nervous system disorder—Ramipril—type 2 diabetes mellitus	5.59e-05	0.000292	CcSEcCtD
Hydromorphone—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.59e-05	0.000292	CcSEcCtD
Hydromorphone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.59e-05	0.000292	CcSEcCtD
Hydromorphone—Tachycardia—Ramipril—type 2 diabetes mellitus	5.57e-05	0.000291	CcSEcCtD
Hydromorphone—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.56e-05	0.00029	CcSEcCtD
Hydromorphone—Skin disorder—Ramipril—type 2 diabetes mellitus	5.54e-05	0.000289	CcSEcCtD
Hydromorphone—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	5.52e-05	0.000288	CcSEcCtD
Hydromorphone—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.48e-05	0.000286	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.44e-05	0.000284	CcSEcCtD
Hydromorphone—Dizziness—Valsartan—type 2 diabetes mellitus	5.44e-05	0.000284	CcSEcCtD
Hydromorphone—Anorexia—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000284	CcSEcCtD
Hydromorphone—Dizziness—Orlistat—type 2 diabetes mellitus	5.38e-05	0.000281	CcSEcCtD
Hydromorphone—Asthenia—Metformin—type 2 diabetes mellitus	5.37e-05	0.000281	CcSEcCtD
Hydromorphone—Hypotension—Ramipril—type 2 diabetes mellitus	5.33e-05	0.000278	CcSEcCtD
Hydromorphone—Nausea—Gliclazide—type 2 diabetes mellitus	5.32e-05	0.000278	CcSEcCtD
Hydromorphone—Pruritus—Metformin—type 2 diabetes mellitus	5.3e-05	0.000277	CcSEcCtD
Hydromorphone—Urticaria—Losartan—type 2 diabetes mellitus	5.29e-05	0.000276	CcSEcCtD
Hydromorphone—Body temperature increased—Losartan—type 2 diabetes mellitus	5.26e-05	0.000275	CcSEcCtD
Hydromorphone—Abdominal pain—Losartan—type 2 diabetes mellitus	5.26e-05	0.000275	CcSEcCtD
Hydromorphone—Vomiting—Valsartan—type 2 diabetes mellitus	5.23e-05	0.000273	CcSEcCtD
Hydromorphone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.21e-05	0.000272	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.2e-05	0.000271	CcSEcCtD
Hydromorphone—Rash—Valsartan—type 2 diabetes mellitus	5.19e-05	0.000271	CcSEcCtD
Hydromorphone—Dermatitis—Valsartan—type 2 diabetes mellitus	5.18e-05	0.000271	CcSEcCtD
Hydromorphone—Vomiting—Orlistat—type 2 diabetes mellitus	5.17e-05	0.00027	CcSEcCtD
Hydromorphone—Insomnia—Ramipril—type 2 diabetes mellitus	5.16e-05	0.000269	CcSEcCtD
Hydromorphone—Headache—Valsartan—type 2 diabetes mellitus	5.15e-05	0.000269	CcSEcCtD
Hydromorphone—Diarrhoea—Metformin—type 2 diabetes mellitus	5.13e-05	0.000268	CcSEcCtD
Hydromorphone—Rash—Orlistat—type 2 diabetes mellitus	5.13e-05	0.000268	CcSEcCtD
Hydromorphone—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.12e-05	0.000267	CcSEcCtD
Hydromorphone—Dermatitis—Orlistat—type 2 diabetes mellitus	5.12e-05	0.000267	CcSEcCtD
Hydromorphone—Headache—Orlistat—type 2 diabetes mellitus	5.09e-05	0.000266	CcSEcCtD
Hydromorphone—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.09e-05	0.000266	CcSEcCtD
Hydromorphone—Asthenia—Irbesartan—type 2 diabetes mellitus	5.07e-05	0.000265	CcSEcCtD
Hydromorphone—Somnolence—Ramipril—type 2 diabetes mellitus	5.07e-05	0.000265	CcSEcCtD
Hydromorphone—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.02e-05	0.000262	CcSEcCtD
Hydromorphone—Pruritus—Irbesartan—type 2 diabetes mellitus	5e-05	0.000261	CcSEcCtD
Hydromorphone—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.96e-05	0.000259	CcSEcCtD
Hydromorphone—Dizziness—Metformin—type 2 diabetes mellitus	4.95e-05	0.000259	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.93e-05	0.000257	CcSEcCtD
Hydromorphone—Fatigue—Ramipril—type 2 diabetes mellitus	4.92e-05	0.000257	CcSEcCtD
Hydromorphone—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.9e-05	0.000256	CcSEcCtD
Hydromorphone—Nausea—Valsartan—type 2 diabetes mellitus	4.89e-05	0.000255	CcSEcCtD
Hydromorphone—Constipation—Ramipril—type 2 diabetes mellitus	4.88e-05	0.000255	CcSEcCtD
Hydromorphone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.84e-05	0.000253	CcSEcCtD
Hydromorphone—Nausea—Orlistat—type 2 diabetes mellitus	4.83e-05	0.000252	CcSEcCtD
Hydromorphone—Asthenia—Losartan—type 2 diabetes mellitus	4.77e-05	0.000249	CcSEcCtD
Hydromorphone—Vomiting—Metformin—type 2 diabetes mellitus	4.76e-05	0.000249	CcSEcCtD
Hydromorphone—Rash—Metformin—type 2 diabetes mellitus	4.72e-05	0.000247	CcSEcCtD
Hydromorphone—Dermatitis—Metformin—type 2 diabetes mellitus	4.72e-05	0.000246	CcSEcCtD
Hydromorphone—Pruritus—Losartan—type 2 diabetes mellitus	4.71e-05	0.000246	CcSEcCtD
Hydromorphone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.7e-05	0.000245	CcSEcCtD
Hydromorphone—Headache—Metformin—type 2 diabetes mellitus	4.69e-05	0.000245	CcSEcCtD
Hydromorphone—Dizziness—Irbesartan—type 2 diabetes mellitus	4.68e-05	0.000244	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.67e-05	0.000244	CcSEcCtD
Hydromorphone—Diarrhoea—Losartan—type 2 diabetes mellitus	4.55e-05	0.000238	CcSEcCtD
Hydromorphone—Urticaria—Ramipril—type 2 diabetes mellitus	4.53e-05	0.000237	CcSEcCtD
Hydromorphone—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.51e-05	0.000235	CcSEcCtD
Hydromorphone—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.51e-05	0.000235	CcSEcCtD
Hydromorphone—Vomiting—Irbesartan—type 2 diabetes mellitus	4.49e-05	0.000235	CcSEcCtD
Hydromorphone—Rash—Irbesartan—type 2 diabetes mellitus	4.46e-05	0.000233	CcSEcCtD
Hydromorphone—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.45e-05	0.000233	CcSEcCtD
Hydromorphone—Nausea—Metformin—type 2 diabetes mellitus	4.45e-05	0.000232	CcSEcCtD
Hydromorphone—Headache—Irbesartan—type 2 diabetes mellitus	4.43e-05	0.000231	CcSEcCtD
Hydromorphone—Dizziness—Losartan—type 2 diabetes mellitus	4.4e-05	0.00023	CcSEcCtD
Hydromorphone—Vomiting—Losartan—type 2 diabetes mellitus	4.23e-05	0.000221	CcSEcCtD
Hydromorphone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.2e-05	0.000219	CcSEcCtD
Hydromorphone—Nausea—Irbesartan—type 2 diabetes mellitus	4.2e-05	0.000219	CcSEcCtD
Hydromorphone—Rash—Losartan—type 2 diabetes mellitus	4.19e-05	0.000219	CcSEcCtD
Hydromorphone—Dermatitis—Losartan—type 2 diabetes mellitus	4.19e-05	0.000219	CcSEcCtD
Hydromorphone—Headache—Losartan—type 2 diabetes mellitus	4.17e-05	0.000218	CcSEcCtD
Hydromorphone—Asthenia—Ramipril—type 2 diabetes mellitus	4.09e-05	0.000214	CcSEcCtD
Hydromorphone—Pruritus—Ramipril—type 2 diabetes mellitus	4.04e-05	0.000211	CcSEcCtD
Hydromorphone—Nausea—Losartan—type 2 diabetes mellitus	3.95e-05	0.000206	CcSEcCtD
Hydromorphone—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.9e-05	0.000204	CcSEcCtD
Hydromorphone—Dizziness—Ramipril—type 2 diabetes mellitus	3.77e-05	0.000197	CcSEcCtD
Hydromorphone—Vomiting—Ramipril—type 2 diabetes mellitus	3.63e-05	0.000189	CcSEcCtD
Hydromorphone—Rash—Ramipril—type 2 diabetes mellitus	3.6e-05	0.000188	CcSEcCtD
Hydromorphone—Dermatitis—Ramipril—type 2 diabetes mellitus	3.59e-05	0.000188	CcSEcCtD
Hydromorphone—Headache—Ramipril—type 2 diabetes mellitus	3.57e-05	0.000187	CcSEcCtD
Hydromorphone—Nausea—Ramipril—type 2 diabetes mellitus	3.39e-05	0.000177	CcSEcCtD
Hydromorphone—OPRD1—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.29e-06	9.56e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.28e-06	9.55e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.25e-06	9.51e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.18e-06	9.43e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	7.08e-06	9.28e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	7.03e-06	9.23e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	7.03e-06	9.23e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—C3—type 2 diabetes mellitus	7.02e-06	9.21e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	7.01e-06	9.2e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	7e-06	9.18e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PPARG—type 2 diabetes mellitus	6.96e-06	9.14e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	6.93e-06	9.1e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	6.93e-06	9.1e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.92e-06	9.08e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.9e-06	9.05e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	6.87e-06	9.02e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	6.87e-06	9.02e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	6.87e-06	9.01e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—INS—type 2 diabetes mellitus	6.83e-06	8.96e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	6.8e-06	8.92e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	6.77e-06	8.88e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	6.77e-06	8.88e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	6.75e-06	8.86e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	6.75e-06	8.86e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	6.75e-06	8.86e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	6.74e-06	8.84e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	6.71e-06	8.81e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.7e-06	8.79e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	6.7e-06	8.79e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	6.7e-06	8.79e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	6.7e-06	8.79e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.69e-06	8.78e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.68e-06	8.76e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	6.67e-06	8.75e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	6.66e-06	8.73e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.65e-06	8.73e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	6.65e-06	8.73e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.61e-06	8.67e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.61e-06	8.67e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—INS—type 2 diabetes mellitus	6.61e-06	8.67e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	6.59e-06	8.65e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.56e-06	8.61e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	6.54e-06	8.58e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.54e-06	8.58e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.54e-06	8.58e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.54e-06	8.58e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	6.54e-06	8.58e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	6.54e-06	8.58e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	6.54e-06	8.58e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	6.52e-06	8.55e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	6.52e-06	8.55e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.5e-06	8.53e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	6.46e-06	8.48e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.46e-06	8.48e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	6.44e-06	8.45e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.39e-06	8.38e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.39e-06	8.38e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.36e-06	8.34e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—ALB—type 2 diabetes mellitus	6.26e-06	8.21e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—RELA—type 2 diabetes mellitus	6.22e-06	8.16e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.16e-06	8.09e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	6.15e-06	8.07e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.07e-06	7.96e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	6.06e-06	7.95e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	6.06e-06	7.95e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	6.06e-06	7.95e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.02e-06	7.9e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	6.01e-06	7.88e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	6.01e-06	7.88e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	6.01e-06	7.88e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PIK3R1—type 2 diabetes mellitus	5.99e-06	7.86e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—NOS3—type 2 diabetes mellitus	5.99e-06	7.86e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	5.95e-06	7.8e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	5.9e-06	7.74e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	5.89e-06	7.73e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	5.84e-06	7.67e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.83e-06	7.65e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.79e-06	7.6e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.79e-06	7.6e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	5.77e-06	7.57e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.76e-06	7.56e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.76e-06	7.55e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	5.72e-06	7.5e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	5.68e-06	7.45e-05	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.66e-06	7.43e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.61e-06	7.36e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—INS—type 2 diabetes mellitus	5.58e-06	7.33e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.57e-06	7.31e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—INS—type 2 diabetes mellitus	5.57e-06	7.3e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.56e-06	7.29e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.56e-06	7.29e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.56e-06	7.29e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.56e-06	7.29e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	5.54e-06	7.27e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	5.49e-06	7.21e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.49e-06	7.21e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	5.48e-06	7.19e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	5.48e-06	7.19e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PTGS2—type 2 diabetes mellitus	5.48e-06	7.19e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—RELA—type 2 diabetes mellitus	5.45e-06	7.16e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	5.43e-06	7.13e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	5.43e-06	7.13e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.4e-06	7.09e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.4e-06	7.08e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.37e-06	7.05e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	5.34e-06	7.01e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.33e-06	6.99e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.3e-06	6.96e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	5.3e-06	6.95e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.27e-06	6.92e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	5.25e-06	6.89e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	5.25e-06	6.89e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.24e-06	6.88e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	5.21e-06	6.83e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	5.21e-06	6.83e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.14e-06	6.75e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.13e-06	6.73e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	5.1e-06	6.7e-05	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.96e-06	6.51e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.95e-06	6.5e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.92e-06	6.45e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.9e-06	6.42e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.9e-06	6.42e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.89e-06	6.41e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.89e-06	6.41e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	4.88e-06	6.41e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.88e-06	6.41e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.76e-06	6.25e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.65e-06	6.1e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.63e-06	6.07e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.61e-06	6.05e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.6e-06	6.03e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.53e-06	5.95e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.53e-06	5.95e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	4.53e-06	5.94e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.53e-06	5.94e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.51e-06	5.92e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	4.51e-06	5.91e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.49e-06	5.89e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	4.49e-06	5.89e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	4.47e-06	5.86e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	4.46e-06	5.86e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	4.45e-06	5.83e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.44e-06	5.83e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.42e-06	5.79e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.42e-06	5.79e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.42e-06	5.79e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	4.41e-06	5.78e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.39e-06	5.76e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.37e-06	5.73e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	4.32e-06	5.66e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.31e-06	5.66e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.29e-06	5.62e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.28e-06	5.62e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	4.28e-06	5.62e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.26e-06	5.59e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	4.2e-06	5.51e-05	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.2e-06	5.51e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.17e-06	5.48e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	4.16e-06	5.46e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.16e-06	5.45e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.13e-06	5.42e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	4.12e-06	5.41e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	4.09e-06	5.36e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	4.04e-06	5.3e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	4.02e-06	5.28e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	4e-06	5.25e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.99e-06	5.23e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.96e-06	5.2e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.96e-06	5.2e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.96e-06	5.2e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.93e-06	5.15e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.92e-06	5.14e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.89e-06	5.1e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.89e-06	5.1e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	3.88e-06	5.09e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.87e-06	5.07e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.85e-06	5.06e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	3.83e-06	5.03e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.83e-06	5.03e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.81e-06	5e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.77e-06	4.95e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.76e-06	4.93e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.71e-06	4.87e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.68e-06	4.83e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.64e-06	4.78e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.62e-06	4.75e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.62e-06	4.75e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.61e-06	4.74e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.58e-06	4.7e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.58e-06	4.7e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.53e-06	4.63e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	3.53e-06	4.63e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	3.5e-06	4.59e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	3.47e-06	4.55e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	3.46e-06	4.53e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	3.44e-06	4.51e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.43e-06	4.51e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.43e-06	4.51e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	3.43e-06	4.49e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	3.42e-06	4.48e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	3.39e-06	4.44e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.29e-06	4.32e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.24e-06	4.25e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.17e-06	4.17e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.04e-06	3.98e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	3.01e-06	3.95e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.98e-06	3.91e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.96e-06	3.88e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.96e-06	3.88e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.95e-06	3.87e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.95e-06	3.87e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.93e-06	3.84e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.91e-06	3.81e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.89e-06	3.79e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.82e-06	3.7e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—AKT1—type 2 diabetes mellitus	2.75e-06	3.61e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.75e-06	3.6e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.71e-06	3.55e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.7e-06	3.54e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.68e-06	3.52e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.66e-06	3.49e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.64e-06	3.46e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.63e-06	3.45e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.59e-06	3.4e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.59e-06	3.4e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.57e-06	3.37e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.57e-06	3.37e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.56e-06	3.36e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.53e-06	3.32e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.44e-06	3.2e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.43e-06	3.18e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.38e-06	3.12e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.37e-06	3.11e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.35e-06	3.08e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.31e-06	3.03e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.27e-06	2.97e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.26e-06	2.96e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.25e-06	2.95e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	2.24e-06	2.94e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.23e-06	2.93e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.97e-06	2.58e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.93e-06	2.53e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.77e-06	2.32e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.69e-06	2.22e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.69e-06	2.22e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.55e-06	2.03e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.19e-06	1.56e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.18e-06	1.55e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.78e-07	1.02e-05	CbGpPWpGaD
